Search Within

David Barron

Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (8)
  2. Department of Medicine (8)
  3. Department of Pathology and Laboratory Medicine (8)
  4. Epidemiology and Biostatistics (8)
  5. GSK Faculty (8)
  6. Genitourinary Oncology Service (8)

More Groups

People
  1. David Solit (8)
  2. Michael Berger (8)
  3. Ahmet Zehir (7)
  4. Maria Arcila (7)
  5. Marc Ladanyi (6)
  6. Emmet Jordan (5)

More People

Years
  1. 2019 (2)
  2. 2017 (5)
  3. 2016 (3)
  4. 2014 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. International Journal of Radiation Oncology, Biology, Physics (2)
  3. Cancer Discovery (1)
  4. Clinical and Translational Radiation Oncology (1)
  5. European Urology (1)
  6. JCO Precision Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier Inc. (3)
  3. Nature Publishing Group (2)
  4. American Association for Cancer Research (1)
  5. Elsevier Science, Inc. (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT)
    Journal Article

    Lockney, N. A.; Yang, T. J.; Barron, D.; Gelb, E.; Gelblum, D. Y.; Yorke, E.; Shi, W.; Zhang, Z.; Rimner, A.; Wu, A. J.
    Clinical and Translational Radiation Oncology (2017)

    Fulltext@MSK | Save
  • PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy
    Meeting Abstract

    Lockney, N. A.; Yang, T. J.; Barron, D.; Gelb, E.; Gelblum, D.; Yorke, E. D.; Rimner, A.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies
    Journal Article

    Jordan, E. J.; Kim, H. R.; Arcila, M. E.; Barron, D.; Chakravarty, D.; Gao, J. J.; Chang, M. T.; Ni, A.; Kundra, R.; Jonsson, P.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Differences in somatic DNA damage repair (DDR) gene alterations between primary and secondary muscle invasive bladder cancer (MIBC)
    Meeting Abstract

    Pietzak, E. J.; Bagrodia, A.; Li, Q.; Al-Ahmadie, H.; Herr, H. W.; Funt, S.; Barron, D.; Zehir, A.; Berger, M. F.; Solit, D. B.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identifying HER2 mutation, amplification, and HER2 protein overexpression as therapeutic targets in lung cancers
    Meeting Abstract

    Li, B. T.; Zheng, T.; Ni, A.; Hellmann, M. D.; Jordan, E.; Barron, D.; Smyth, L. M.; Solit, D. B.; Zehir, A.; Ross, D. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection
    Meeting Abstract

    Jordan, E.; Barron, D.; Schultz, N.; Chakravarty, D.; Kris, M. G.; Rudin, C. M.; Li, B. T.; Yu, H. A.; Drilon, A. E.; Rusch, V. W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save